Antiemetic Effectiveness and Cost-Saving of Aprepitant plus Granisetron Is Superior to Palonosetron in Gastrointestinal Cancer Patients Who Received Moderately Emetogenic Chemotherapy.

导出 OA

翻译打印收藏纠错

作者： Haruka,Toda ^[1] ; Hitoshi,Kawazoe ^[1] ; Akiko,Yano ^[1] ; Yuji,Yamamoto ^[2] ; Yuji,Watanabe ^[2] ; Yasunori,Yamamoto ^[3] ; Yoichi,Hiasa ^[4] ; Yoshihiro,Yakushijin ^[5] ; Akihiro,Tanaka ^[1] ; Hiroaki,Araki ^[1]

作者单位： Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime 791-0295, Japan. ^[1] Division of Gastrointestinal Surgery and Surgical Oncology, Department of Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan. ^[2] Endoscopy Center, Ehime University Hospital, Shitsukawa, Toon, Ehime 791-0295, Japan. ^[3] Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan. ^[4] Cancer Center, Ehime University Hospital, Shitsukawa, Toon, Ehime 791-0295, Japan. ^[5]

关键词 aprepitant cost-saving.gastrointestinal cancer moderately emetogenic chemotherapy palonosetron

DOI 10.7150/jca.17102

PMID 28638451

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交